04 March 2024 1 Min Read
NEWS LEADER
WATCH: Aspen interim earning drop 6%
Business Day TV speaks to CEO Stephen Saad
in Companies / Healthcare
Loading ...
Aspen has posted a 10% rise in interim revenue, supported by growth in commercial pharmaceuticals, as well as manufacturing. The pharmaceutical group’s bottom line however took a knock, as headline earnings per share dropped 6%. Business Day TV spoke to CEO Stephen Saad for more detail.